Silence Therapeutics (SLN) Return on Assets (2021 - 2026)

Silence Therapeutics' Return on Assets history runs 6 years deep, the most recent figure standing at 0.01% for Q1 2026.

• In Q1 2026, Return on Assets changed 0.0% year-over-year to 0.01%; the TTM figure through Mar 2026 stood at 0.01% (changed 0.0% YoY), while the FY2025 annual figure was 0.01%, changed 0.0% from the prior year.
• Return on Assets came in at 0.01% for Q1 2026 at Silence Therapeutics, up from 0.01% in the prior quarter.
• In the past five years, Return on Assets ranged from a high of 0.0% in Q2 2024 to a low of 0.01% in Q4 2025.
• A 5-year average of 0.0% and a median of 0.0% in 2023 frame the typical range for Return on Assets.
• Across the five-year window, Return on Assets changed 0 bps in 2022 and retreated 1 bps in 2025, its largest moves.
• Silence Therapeutics' Return on Assets stood at 0.0% in 2022, then declined by 11 bps to 0.0% in 2023, then advanced by 24 bps to 0.0% in 2024, then slumped by 545 bps to 0.01% in 2025, then rose by 4 bps to 0.01% in 2026.
• According to Business Quant data, Return on Assets over the past three periods registered 0.01%, 0.01%, and 0.0% for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison